Brokerage firms Nuvama, CLSA, and Macquarie have highlighted strong growth prospects for TCS, Bajaj Finance, and IRCTC, ...

Dr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.

India's economy is experiencing subdued demand and slower growth across sectors due to weak household incomes and sluggish ...

TCS shares surge 6% post Q3 results, brokerages optimistic, net profit up 5.5%, dividend declared, target prices revised.

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...

Avenue Supermarts, operator of DMart, is expected to report an 18% YoY revenue growth to Rs 16,016 crore for Q3FY25, with net ...

Tata Consultancy Services have 'Buy' ratings from brokers despite mixed Q3 FY25 results; discover insights on stock ...